✦ LIBER ✦

BRCA2 gene mutations in Greek patients with familial breast cancer

✍ Scribed by Athanasios Armakolas; Angela Ladopoulou; Irene Konstantopoulou; B. Pararas; Ilias P. Gomatos; Agapi Kataki; Manoussos M. Konstadoulakis; George P. Stathopoulos; Christopher Markopoulos; Emmanouil Leandros; Ioannis Gogas; Drakoulis Yannoukakos; George Androulakis

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 37 KB
Volume: 19
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.9003

No coin nor oath required. For personal study only.

✦ Synopsis

Family history is a well-recognized risk factor for the development of breast cancer. The isolation of BRCA1 and BRCA2 genes, the two major predisposing genes in familial and to early onset breast and ovarian cancer, has resulted to the identification of a large number of families with mutations in these two genes. Despite the large number of distinct mutations detected in both genes, several mutations have been found to recur in unrelated families of diverse geographical origin. We have analyzed 27 Greek patients with familial breast cancer the majority of those having one first and one second degree relatives affected and 28 patients with sporadic breast cancer for BRCA2 germline mutations. The techniques used were single-strand conformation polymorphism analysis (SSCP) followed by sequencing. Furthermore, the clinical presentation and prognosis of BRCA2 associated breast cancer cases was compared to 20 adequately matched for age and date of diagnosis (within one year ) sporadic breast cancer patients. We identified three novel BRCA2 mutations (3058delA, 6024delTA, and 4147delG) in the ovarian cancer cluster region (OCCR) and one already known (2024del5) germline BRCA2 gene mutation in five different breast cancer families. The 4147delG mutation was detected in two unrelated patients. BRCA2 germline mutations were correlated with early-onset breast cancer RR=4.77 (95% CI: 0.666-34.463). Although patients with BRCA2 germline mutations did not have a distinct histological phenotype they had an improved overall survival (100% vs 65%). Our findings suggest that there is a cluster of novel mutations in exons 10 and 11 in Greek patients with familial breast cancer. These mutations appear to have a milder clinical phenotype when compared to the rest of the study group.

📜 SIMILAR VOLUMES

BRCA2 germline mutations in Cypriot pati

BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancer

✍ Andreas Hadjisavvas; Elpida Charalambous; Adamos Adamou; Christina G. Christodou 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 29 KB 👁 2 views

Germline mutations in the BRCA2 gene have been shown to be associated with familial female and male breast cancer. Mutations occur throughout the entire coding region of the gene, and there is considerable ethnic and geographical diversity in the deleterious mutations detected in different populatio

BRCA1 and BRCA2 mutations in Russian fam

BRCA1 and BRCA2 mutations in Russian familial breast cancer

✍ Irina V. Tereschenko; Victoria M. Basham; Bruce A.J. Ponder; Paul D.P. Pharoah 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB 👁 2 views

We have screened index cases from 25 Russian breast/ovarian cancer families for germ-line mutations in all coding exons of the BRCA1 and BRCA2 genes, using multiplex heteroduplex analysis. In addition we tested 22 patients with breast cancer diagnosed before age 40 without family history and 6 patie

BRCA2 germline mutations in Japanese bre

BRCA2 germline mutations in Japanese breast cancer families

✍ Rie Inoue; Toshikazu Ushijima; Takashi Fukutomi; Atsuo Fukami; Haruhiko Sugimura 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 125 KB 👁 2 views

Germline mutations of BRCA2 were examined in 20 Japanese breast cancer families without BRCA1 mutations, including one demonstrating cancer development in a male. Three different mutations, resulting in truncation of the BRCA2 protein, were detected in 3 different families. They were 9474insA (exon

BRCA1 germline mutations in Indian famil

BRCA1 germline mutations in Indian familial breast cancer

✍ Mani T. Valarmathi; Agarwal A.; Suryanarayana S. V. Deo; Nootan K. Shukla; Satya 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 1 views

Germline mutation analysis of BRCA1 gene has demonstrated significant allelic heterogeneity. These differences represent historical influences of migration, population structure and geographic or cultural isolation. To date, there have been no reports of Indian families with mutations in BRCA1. We h

BRCA1 mutations in German breast-cancer

BRCA1 mutations in German breast-cancer families

✍ Burkhard Jandrig; Klaus Grade; Susanne Seitz; Beate Waindzoch; Manuela Müller; E 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 488 KB 👁 2 views

We analyzed germline mutations of the BRCAl gene in 20 German breast/ovarian-cancer families. BRCA I mutations cosegregating with breast-cancer susceptibility were identified in 3 of these families. All mutations were found to generate a premature stop codon leading to the synthesis of truncated BRC

Germline mutations in the BRCA1 and BRCA

Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients

✍ A. Esra Manguoǧlu; Güven Lüleci; Tayfun Özçelik; Taner Çolak; Hagit Schayek; Mus 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 47 KB 👁 2 views

In this study we genotyped Turkish breast/ovarian cancer patients for BRCA1/BRCA2 mutations: protein truncation test (PTT) for exon 11 BRCA1 of and, multiplex PCR and denaturing gradient gel electrophoresis (DGGE) for BRCA2, complemented by DNA sequencing. In addition, a modified restriction assay w